CHINESE HOSPITAL — History
CCN 050407 | 3-year financial timeline | COVID resilience: 76/100
🛡️ Public data only — no PHI permitted on this instance.
$90M
Latest Revenue (FY2022)
+11.0%
Revenue CAGR (3yr)
-59.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $73M | $84M | $90M | +7.3% | +11.0% |
| Operating Expenses | $127M | $135M | $143M | +6.1% | +6.2% |
| Operating Margin | -73.7% | -60.9% | -59.1% | +2.8% | +0.0% |
| Net Income | $-54M | $-51M | $-53M | -4.2% | +0.0% |
| Licensed Beds | 88 | 80 | 80 | +0.0% | -4.7% |
| Total Patient Days | 11,337 | 9,471 | 12,524 | +32.2% | +5.1% |
| Medicare Day % | 19% | 24% | 19% | -18.6% | -0.6% |
| Medicaid Day % | 1% | 0% | 1% | +96.3% | -18.2% |
COVID Impact & Recovery
Resilience Score: 76/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +23.1% ($73M → $90M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+11.0%
This Hospital
+7.6%
State Avg
Latest Margin
-59.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $98M | -51.8% |
| FY2024 (proj) | $107M | -44.6% |
| FY2025 (proj) | $115M | -37.3% |